August 4, 2025
About RSV Related Respiratory Disease Respiratory Syncytial Virus (RSV) can cause significant lower respiratory tract disease (LRTD) in older patients, especially those with comorbidities identified by the CDC as heightened risk factors- asthma, diabetes, COPD, CHF, or advanced liver or kidney disease. Each year, an estimated 110,000–180,000 adults ages 50 and older in the United…
October 20, 2023
Common Fall & Winter Respiratory Illnesses Circulating respiratory viruses such as COVID-19, influenza (flu) and respiratory syncytial virus (RSV) aremore common in fall and winter, and can lead to significant illness and disease. COVID-19, flu and RSV are each caused by a different virus. They are considered respiratory viruses, as all three spread primarily by…
August 16, 2023
FDA Approves First RSV Vaccines In May 2023, the Food and Drug Administration (FDA) approved the first vaccines for prevention of RSV associated lower respiratory tract disease (LRTD) in adults aged ≥60 years. RSVPreF3 (Arexvy, GSK) is a 1-dose (0.5 mL) adjuvanted (AS01E) recombinant stabilized prefusion F protein (preF) vaccine. RSVpreF (Abrysvo, Pfizer) is a…
Categories
